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Abstract
Objective The aim of this study was to evaluate the
relationships between the serum levels of adiponectin
(ADP) and matrix metalloproteinase-9 (MMP-9) and
postoperative cognitive dysfunction (POCD) in elderly
patients after general anesthesia.
Methods The cognitive functions of 98 elderly patients
who were scheduled to undergo selective hip replacement
surgery under general anesthesia were assessed using the
Montreal Cognitive Assessment (MoCA) 3 days before
surgery and on postoperative Days 1, 2, 3, and 7. The
serum levels of ADP and MMP-9 were determined at the
same time points, and the presence of POCD on postop-
erative Day 3 was recorded. The patients were divided into
a POCD group and non-POCD group.
Results Postoperative cognitive dysfunction was
observed in 28 patients (28.5 %). Serum MMP-9 levels
significantly increased and serum ADP levels significantly
decreased in the POCD group at each postoperative time
point and in the non-POCD group on postoperative Days 1
and 2 compared to the presurgical levels. Serum MMP-9
levels were significantly higher and serum ADP levels were
significantly lower in the POCD group compared with
those in the non-POCD group at each time point. In the
POCD patients, serum MMP-9 levels were significantly
and negatively correlated and serum ADP levels were
significantly and positively correlated with the MoCA
scores.
Conclusions The increased serum MMP-9 levels and
decreased serum ADP levels in elderly patients after gen-
eral anesthesia might be involved in the POCD patho-
physiological process.
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Introduction
Postoperative cognitive dysfunction (POCD), which is a
common postoperative complication in elderly patients,
delays patient recovery and prolongs their hospitalization.
The occurrence of POCD might be related to multiple risk
factors, including anesthesia, surgery, and perioperative
status, and the mechanisms underlying its occurrence are
currently unclear. Adiponectin (ADP), which is a protein
hormone that is derived from fat cells and is secreted by fat
tissues, has many bioactivities, including anti-inflamma-
tion, anti-oxidation, and blood sugar reduction. Thus, ADP
might have protective effects towards cells, tissues, and
organs [1–5], and ADP has been shown to effectively
reduce the secretion of central proinflammatory cytokines
[6]. The main functions of matrix metalloproteinase-9
(MMP-9), which is a member of a group of Zn2?-depen-
dent proteolytic enzymes, are to degrade and remodel the
extracellular matrix. MMP-9 plays a major role in
degrading the basal membrane. The abnormal expression
of MMP-9 has been directly related to disruption of the
blood–brain barrier, and it is a key factor in vasogenic
edema and secondary brain injuries. The overexpression of
& Haihui Xie
haihuixiecn@126.com
1 Department of Anesthesiology, Dongguan People’s Hospital,
Dongguan 5230181, Guangdong, China
2 Department of Osteology, Dongguan People’s Hospital,
Dongguan 5230181, Guangdong, China
123
Aging Clin Exp Res (2016) 28:1075–1079
DOI 10.1007/s40520-015-0519-9
MMP-9 affects the integrity of the vascular basal mem-
brane, thus resulting in severe blood–brain barrier damage
and the entry of plasma proteins and a variety of substances
and metabolites into the brain, which causes vasogenic
edema and the entry of inflammatory cells into brain tissues
[7–9]. Reductions in the expression of MMP-9 have been
shown to significantly improve cerebral ischemia–reper-
fusion injuries in rats [10]. However, it is unclear if serum
ADP and MMP-9 are involved in the pathophysiological
processes underlying POCD. This study was designed to
investigate the relationships between serum ADP and
MMP-9 levels and POCD in elderly patients after general




This study was conducted in accordance with the Decla-
ration of Helsinki. This study was conducted with approval
from the Ethics Committee of Dongguan People’s Hospi-
tal. Written informed consent was obtained from all par-
ticipants. A total of 98 elderly patients who were scheduled
to undergo selective total hip replacement surgery while
under general anesthesia were enrolled in the study. The
patients were classified as grades II or III of the American
Society of Anesthesiologists. They had an age range of
65–83 years and included 63 males and 35 females. The
exclusion criteria were any of the following: (1) Montreal
Cognitive Assessment (MoCA) score less than 26 points
3 days before the surgery; (2) inability to recognize the text
on the cognitive test forms; (3) comorbidity of significant
diseases of the respiratory system, circulatory system, liver,
kidney, or nervous system; (4) presence of diabetes before
the surgery; (5) treatment with antipsychotic drugs, seda-
tives, or narcotic analgesics within 2 years; (6) history of
alcohol abuse or drug dependence; (7) comorbidity of
severe visual or hearing impairments or other reasons that
would cause communication problems with the inter-
viewer; (8) unsatisfactory surgical results necessitating an
immediate second surgery; (9) operation time over 3 h; or
(10) intraoperative blood loss over 800 mL. The patients
were divided into a POCD group and non-POCD group
based on the presence of POCD 3 days after the surgery.
Anesthetic methods
The patients were fasted for 8–10 h and forbidden water
for 4 h before the surgery. After entering the operating
room and confirming the patient, the peripheral vein of the
upper extremity was opened, and radial artery puncture was
performed. Electrocardiograms, peripheral capillary oxy-
gen saturation, respiratory rate, and partial pressure of end-
tidal carbon dioxide were monitored, and a Narcotrend
monitor was used to measure the depth of anesthesia. All of
the patients were treated with endotracheal general anes-
thesia without preoperative medication. General anesthesia
was induced by intravenous injections of midazolam
(0.05–0.1 mg/kg, Jiangsu Nhwa Pharmaceutical Corpora-
tion Ltd., Xuzhou, China), etomidate (0.3 mg/kg, Jiangsu
Nhwa Pharmaceutical Corporation Ltd.), fentanyl (3–5 lg/
kg, Yichang Humanwell Pharmaceutical Co., Ltd.,
Yichang, China), and cisatracurium [0.2 mg/kg, Dong
Ying (Jiangsu) Pharmaceutical Co., Ltd., Nantong City,
China]. Mechanical ventilation was performed after intu-
bation, and the partial pressure of the end-tidal carbon
dioxide was maintained at 35–45 mmHg. Intraoperative
anesthesia was maintained by a constant infusion of
propofol (Xi’an Libang Pharmaceutical Co., Ltd., Xi’an,
China), remifentanil (Yichang Humanwell Pharmaceutical
Co., Ltd.), and cisatracurium, and the Narcotrend index
was maintained at D2-E1. During the surgery, urine output,
blood loss, and transfusion volume were recorded, and the
hemodynamics were kept stable. Patient-controlled inter-
scalene analgesia was administered postoperatively. The
analgesics (10 lg/kg fentanyl, 200 mg flurbiprofen, and
6 mg tropisetron) were diluted with saline to make
200 mL. The background infusion rate was 2 mL/h, the
patient controlled analgesic dose was 2 mL, and the lock-
ing time was 15 min. After the surgery, a visual analog
scale scoring system was used to evaluate the degree of
pain (0 points: painless, 10 points: severe pain) in order to
maintain a visual analog scale score of 3 points or less.
Determination of cognitive function
The same researcher who was blind to the grouping of the
patients performed the MoCA (Beijing edition) to assess
the patients’ neuropsychological statuses at the following
time points: 3 days before surgery (T0) and Day 1 (T1),
Day 2 (T2), Day 3 (T3), and Day 7 (T4) after the surgery.
The MoCA assesses seven cognitive areas: visuospatial/
execution, naming, attention, language, abstract, delayed
recall, and orientation. The range of the total score is 0–30
points with 26 points or more indicating normal cognition.
The test time was about 10 min.
Collection and testing of blood samples
Peripheral blood samples (3 mL) were collected from each
patient at each time point. The samples were centrifuged,
and the plasma was preserved at -80 C until further
testing. Double-antibody sandwich enzyme-linked
immunosorbent assay reagent kits (Shanghai Bogu
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Biotechnology Co., Ltd., Shanghai, China) were used to
detect the serum levels of ADP and MMP-9.
Statistical analysis
SPSS (version 17.0, IBM Corporation, Armonk, NY, USA)
software was used for the analysis. The measurement data
were expressed as mean ± standard deviation. Intragroup
comparisons were assessed with repeated measure analyses
of variance. The intergroup comparisons were made with
t tests. The measurement data were assessed with v2 tests,
and the relationships between the serum levels of ADP and
MMP-9 and the MoCA scores in POCD patients were
analyzed with linear correlations. P values less than 0.05
were considered statistically significant.
Results
General characteristics of the two groups
Age, body mass index, anesthesia time, operation time,
intraoperative blood loss, and other variables did not differ
significantly between the two groups (P[ 0.05, Table 1).
MoCA scores of the two groups
The MoCA scores did not differ significantly between the
two groups at T0 (P[ 0.05). The MoCA scores of the
POCD group at T1, T2, T3, and T4 were significantly
lower than that at T0, while those of the non-POCD group
at T1 and T2 were significantly lower than that at T0, and
restored to that at T0 from T3. The intergroup comparison
showed that the MoCA scores of the POCD group at each
time point were significantly lower than those of the non-
POCD group (P\ 0.05, Table 2).
Serum levels of ADP and MMP-9 in the two groups
In the POCD group, the MMP-9 serum levels at T1, T2,
T3, and T4 were significantly higher than the levels at T0
(P\ 0.05), while the ADP serum levels at T1, T2, T3, and
T4 were significantly lower than the levels at T0
(P\ 0.05). In the non-POCD group, the MMP-9 serum
levels at T1 and T2 were significantly increased compared
to the T0 level (P\ 0.05), while the ADP serum levels at
T1 and T2 were significantly decreased compared to the T0
levels (P\ 0.05), and the levels of both were restored to
the preoperative level at T3. The intergroup comparison
showed that the serum MMP-9 levels of the POCD group at
each postsurgical time point were significantly higher than
those of the non-POCD group (P\ 0.05), and the serum
ADP levels of the POCD group at each postsurgical time
point were significantly lower than those of the non-POCD
group (P\ 0.05, Table 3).
Relationships of serum ADP and MMP-9 levels
with the MoCA score in the POCD group
The linear correlation analysis showed that the serum
MMP-9 levels were significantly and negatively correlated
with the MoCA score (r = -0.833, P\ 0.01), while the
serum ADP levels were significantly and positively corre-
lated with the MoCA score (r = 0.513, P\ 0.01).
Discussion
POCD is a common postoperative complication in elderly
patients, and the incidence in elderly patients after non-
cardiac surgery ranges from 13 to 47 % [11]. This study
showed that the incidence of POCD in elderly patients was
28.5 %, which was consistent with the findings of previous
reports. The pathogenesis of POCD is complex. Anesthe-
sia, hypoxemia, hypotension, surgical type, anesthetic type,
sleep disorders, and inflammatory reactions all contribute
to POCD [12], but the exact mechanism is still unclear.
Currently, there are no uniform standards for the diagnosis
of POCD, and its diagnosis is still mainly based on neural
psychological measurements. The most commonly used
tools in recent years are the Mini-Mental State Examina-
tion (MMSE) and MoCA. However, the MMSE has a
ceiling effect, and it is therefore not sensitive enough to
detect mild POCD cases. In addition, it is greatly affected
by education, and higher education can produce false
negative results [13]. The MoCA scoring system, which is
suitable for wide age ranges and educational levels, exhi-
bits higher sensitivity and specificity than the MMSE [14].
The MoCA scoring system that was used in this study was
the adapted Beijing version. MoCA scores less than 26
Table 1 Comparison of general information between the two groups (x ± s)
Group n Age BMI Anesthesia time (min) Operation time (min) Intraoperative blood loss (mL)
Non-POCD group 28 75.33 ± 3.30 22.63 ± 2.33 101.63 ± 16.56 83.63 ± 12.33 346.38 ± 73.63
POCD group 70 75.13 ± 5.60 22.38 ± 3.03 102.13 ± 17.63 82.39 ± 17.53 348.39 ± 78.38
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points indicate the presence of POCD. This study examined
elderly patients who required total hip replacement surgery,
experienced similar surgical trauma, and had a high inci-
dence rate of POCD. However, preoperative anxiety, which
is common and which would be much more obvious close
to the time of the surgery, might have affected the earlier
preoperative assessment and reduced the impact of nega-
tive emotions on the assessment results. Therefore, we
performed the MoCA assessment 3 days before the surgery
and strictly controlled the patient’s preoperative cognitive
function state and the amount of anesthetics during the
surgery. Factors that might affect postoperative cognitive
function, including hypoxemia and hypotension, were
avoided in order to obtain comparable results.
Adiponectin is abundant in human plasma, and its
expression and secretion are regulated by a number of
inflammatory cytokines, reactive oxygen species, transcrip-
tion factors, and hormones, such as tumor necrosis factor-a
and interleukin-6, and other inflammatory mediators could
inhibit the expression and secretion of ADP. ADP has a wide
range of cardiovascular effects, including endothelial function
improvements, myocardial hypertrophy remodeling inhibi-
tion, and anti-apoptosis and anti-inflammatory effects.
Recently, the expression of ADP and its receptor (AdipoR)
was observed throughout the pituitary gland and brain. Adi-
poR1 expression in the hypothalamus and basal ganglia sug-
gests that ADP might be involved in the signaling pathway
that controls energy balance as well as certain higher brain
functions [15]. Kamogawa et al. [16] found that the increased
serum levels of ADP in males had protective effects towards
the progression of mild cognitive dysfunction. Studies have
suggested that ADP might improve insulin resistance, thus
improving blood–brain barrier functions and brain receptor
functions [17]. Sakr [18] found that increasing the expression
of AdipoR1 improved cognitive functions and the levels of
acetylcholine in the hypothalamusofdiabetic rats. The present
study found that serumADP levels at T1, T2, T3, andT4 in the
POCD group were significantly lower than that at T0, and the
serum ADP levels of the POCD group at each postsurgical
time point were significantly lower than those of the non-
POCDgroup.These results indicated that the higher incidence
of POCD in elderly patients in the early post-general anes-
thesia stage might be related to a reduction in serum ADP
levels and that ADPmight delay the development of POCD to
some extent. Further statistical analyses showed that the
serumADP levels were significantly and positively correlated
with the MoCA scores, which suggested that ADP was a
protective factor for POCD and that its effects might be
achieved through an anti-inflammatory mechanism.
In recent years, a number of studies have found close
relationships betweenMMP-9 and cerebrovascular diseases,
and these relationships were much more obvious in the
pathological processes underlying inflammatory responses,
cerebral edema, and secondary brain injuries after the onset
of cerebral infarction. These processes affect the degradation
balance of the extracellular matrix, resulting in the occur-
rence of several pathological processes, such as blood–brain
barrier damage and demyelination. MMP-9 is expressed at
low levels in normal brain tissues. Inflammatory cytokines
and hypoxic factors and nerve cells, microglial cells, and
vascular endothelial cells synthesize MMP-9 and degrade
the extracellular matrix, thus aggravating inflammation and
increasing the permeability of the blood–brain barrier, brain
damage, and neurological damage. Serum MMP-9 levels
have been shown to be positively correlatedwith the severity
of cognitive impairment [19]. Gaudet reported that POCD in
elderly patients after cardiac surgerywas related to increased
MMP-9 levels [20]. The present study showed that the serum
Table 2 Comparison of MoCA
between the two groups at
different time points (x ± s)
Group n T0 T1 T2 T3 T4
Non-POCD 28 28.63 ± 1.63 25.86 ± 1.39a 26.73 ± 1.61a 28.18 ± 1.31 28.31 ± 1.33
POCD 70 28.83 ± 1.33 22.53 ± 1.23ab 23.36 ± 1.67ab 24.33 ± 1.84ab 25.98 ± 1.16ab
Compared with T0, a P\ 0.05; compared with the non-POCD group, b P\ 0.05
Table 3 Comparison of serum
levels of ADP and MMP-9
between the two groups at
different time points (x ± s)
Time point MMP-9 (lg/L) ADP (mg/L)
Non-POCD group POCD group Non-POCD group POCD group
n 70 28 70 28
T0 297.9 ± 47.3 293.3 ± 49.8 9.43 ± 1.32 9.39 ± 1.36
T1 438.6 ± 53.3a 536.6 ± 67.6ab 5.73 ± 1.03a 4.33 ± 1.61ab
T2 386.6 ± 66.3a 481.2 ± 63.7ab 6.66 ± 1.38a 4.66 ± 1.23ab
T3 301.3 ± 67.3 431.9 ± 63.9ab 9.13 ± 1.03 5.13 ± 1.63ab
T4 296.9 ± 53.6 393.1 ± 48.3ab 9.38 ± 1.17 6.03 ± 1.13ab
Compared with T0, a P\ 0.05; compared with the non-POCD group, b P\ 0.01
1078 Aging Clin Exp Res (2016) 28:1075–1079
123
MMP-9 levels at T1, T2, T3, and T4 in the POCD groupwere
significantly higher than the levels at T0, while the levels in
the non-POCD group returned to preoperative levels at T3.
Further statistical analysis showed that the serum levels of
MMP-9 in the POCD group were significantly and nega-
tively correlated with theMoCA scores, which indicated that
the higher the postoperative serum MMP-9 levels were, the
lower theMoCAscorewas. These findings suggested that the
increased serum MMP-9 levels in elderly patients after
general anesthesia might be involved in the pathophysio-
logical process of POCD. In addition, we found that the
MoCA scores of 11 patients in the POCD group restored
normal 14 days after the surgery, the serum ADP was sig-
nificantly increased, and the serumMMP-9was significantly
decreased. The post-discharge follow-up revealed that the
MoCA scores of 30 patients restored normal 30 days after
the surgery, and the serum ADP and MMP-9 restored nor-
mal; while the MoCA scores of the other four patients
restored normal 90 days after the surgery.
In summary, the findings of this study suggested that the
decreased serum ADP levels and increased serum MMP-9
levels in elderly patients after general anesthesia might be
involved in the pathophysiological process of POCD.
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